Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
30/07/202407:15GlobeNewswire Inc.HII Declares Quarterly DividendNYSE:HIIHuntington Ingalls Industries Inc
30/07/202407:15GlobeNewswire Inc.Acronis H1 2024 Cyberthreats Report Highlights a 293% Surge in Email Attacks
30/07/202407:15GlobeNewswire Inc.Cassava Sciences Announces Expansion of Open-Label Extension TrialsNASDAQ:SAVACassava Sciences Inc
30/07/202407:15GlobeNewswire Inc.Vislink to Report Second Quarter 2024 Financial Results on Wednesday, August 14, 2024, at 8:30 a.m. ETNASDAQ:VISLVislink Technologies Inc
30/07/202407:15PR Newswire (US)PAVmed to Hold a Business Update Conference Call and Webcast on August 13, 2024NASDAQ:PAVMPAVmed Inc
30/07/202407:15PR Newswire (US)Tamr Launches Tamr RealTime for its AI-Native Data Management Platform
30/07/202407:15PR Newswire (US)Pinetree Therapeutics Closes $17 Million in Series A Funding to Advance AbReptor™ Protein Degradation Platform and Portfolio Programs
30/07/202407:15PR Newswire (US)SCRIVAS DEBUTS MEDICAL SCRIBE AI SOFTWARE TO STREAMLINE OPERATIONS AND ENHANCE THE PATIENT EXPERIENCE
30/07/202407:14Alliance NewsAlliance NewsTOP NEWS: German yearly consumer price inflation rate picks up to 2.3%
30/07/202407:14PR Newswire (Canada)Pluribus Technologies Corp. Announces Further Amendment to Forbearance AgreementTSXV:PLRBPluribus Technologies Corp
30/07/202407:13PR Newswire (US)Made-in-China.com Delivers Exceptional Buyer Value at Mega Show Bangkok
30/07/202407:13PR Newswire (US)V8 Piezo-Walk Technology Powers Vacuum Compatible Nanopositioning Stage, new from PI
30/07/202407:13PR Newswire (US)The Juice Plus+ Company Proudly Supports the United States Performance Center
30/07/202407:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMNNImunon Inc
30/07/202407:12PR Newswire (US)The Winners Circle partners with Racing Club to empower fans with horse ownership opportunities
30/07/202407:11Alliance NewsAlliance NewsIN BRIEF: Foxtons confident for 2024 after UK election out of the wayLSE:FOXTFoxtons Group Plc
30/07/202407:11PR Newswire (Canada)Suspension de la négociation par l'Organisme canadien de réglementation des investissements - ELVTTSXV:ELVTElevation Gold Mining Corporation
30/07/202407:09PR Newswire (Canada)Canadian Investment Regulatory Organization Trading Halt - ELVTTSXV:ELVTElevation Gold Mining Corporation
30/07/202407:08Business WireLeveragen Announces Collaboration Agreement with Moderna Using Proprietary Fully Human Single Domain Antibody Technology to Advance Therapeutics
30/07/202407:08Business WireLumaCyte Launches Laser Force Cytology™ Academy after Training FDA Reviewers
30/07/202407:07PR Newswire (US)J.S. Held Expertise in Global Asset Recovery and Investigations Recognized
30/07/202407:06PR Newswire (US)SAE International Webinar to Feature Amsted Automotive Advanced Multi-Functional Clutch Technology for EV and HEV Multi-Speed Shift Systems
30/07/202407:05Business WireAlliant Financial Institutions Wins Broker Team of Year in the Business Insurance U.S. Insurance Awards
30/07/202407:05PR Newswire (US)Axiad Raises $25M in Private Equity Round from Invictus Growth Partners
30/07/202407:05PR Newswire (US)Exafluence Taps Industry Veteran Joerg Guenther As President & CTO of Financial Services Division
30/07/202407:05PR Newswire (US)More Than Half of U.S. Companies Plan to Add New Positions in the Second Half of 2024NYSE:RHIRobert Half Inc
30/07/202407:05PR Newswire (US)INSBANK Bolsters Accounting and Finance Team for Strategic Growth
30/07/202407:05PR Newswire (US)Cox Automotive's Power of Data Study Reveals While Data Insights Provide Value to Heavy Users, Most Dealers Still Experience Data Challenges
30/07/202407:05PR Newswire (Canada)More Than Half of Canadian Companies Plan to Add New Positions in the Second Half of 2024
30/07/202407:05GlobeNewswire Inc.Yamo Pharmaceuticals Announces Positive Topline Results from Phase 2 Study of L1-79 for the Treatment of the Core Symptoms of Autism